A FOCUS ON SELPERCATINIB’S ROLE IN PRECISION ONCOLOGY
Vaishali Sorte*, Dr. Rupesh Pingale, Dr. Sonali Sonulkar, Karthik Nadar, Reyan Kasab and Sai Mulgi
ABSTRACT
The drugs selpercatinib used for the target therapy for thyroid cancer when other options have been exhausted. In this discussion, we delve into the action mechanism of selpercatinib, exploring its pharmacokinetics, pharmacodynamics, and the array of side effects associated with its use. The information presented is based on a thorough review of research papers and reputable drug databases, including Drug Bank and NIV24.
[Full Text Article] [Download Certificate]